FDA is letting pharmacists prescribe Pfizer's Paxlovid but won't do the same for Merck's Lagevrio

FDA is letting pharmacists prescribe Pfizer's Paxlovid but won't do the same for Merck's Lagevrio

Source: 
Fierce Pharma
snippet: 

Since they were authorized a day apart in December, Pfizer’s Paxlovid and Merck and Ridgeback’s Lagevrio have been linked as twin oral antiviral COVID-19 treatments.